Products and Resources Catalog

    This webinar focuses on increasing knowledge among providers in the assessment and treatment of wounds as related to intravenous drug and xylazine use.     LEARNING OBJECTIVES: Explain opioid use disorder as a chronic illness. Increase level of comfort in the treatment and assessment of wound care as it relates to intravenous drug and Xylazine use. Share best practices for incorporating harm reduction philosophies and principles in the treatment of opioid use disorder (OUD).     TRAINERS:   Nicole Gastala, MD   Dr. Gastala is board certified in Family Medicine and Addiction Medicine. She graduated from Loyola Stritch School of Medicine and completed her Family Medicine residency at the University of Iowa. In her clinical role, she has developed and expanded MAR by mentoring new prescribers, precepting residents, and training clinicians within the Chicago and Illinois communities.  She has also focused on the development of a walk-in integrated behavioral health, addiction, and primary care program within her FQHC system. In January 2021, Dr Gastala joined the team at the Substance Use Prevention and Recovery Division of IDHS as the medical director.     Michael Huyck, NP   Michael Huyck is a Family Nurse Practitioner at the UIH Mile Square Health Center and adjunct clinical assistant professor with the University of Illinois College of Nursing. His clinical role at Mile Square is focused on integrative substance use disorder treatment and primary care. His clinical interests involve decreasing barriers to addiction care, piloting evidenced based interventions to address problems specific to populations with SUD, and training future nurses to care for those experiencing addiction. He provides a full range of SUD treatment including buprenorphine and methadone within his practice. His current projects include wound care and ultrasound guided phlebotomy for people who inject drugs.     The Great Lakes A/MH/PTTC is offering this training for individuals working in HHS Region 5: IL, IN, MI, MN, OH, WI. This training is being provided in response to a need identified by Region 5 stakeholders.

The New England ATTC co-hosted the Recovery Science and Harm Reduction (RSHR) Reading Group meeting on February 24, 2022 from 12:30 PM to 1:30 PM. This discussion reviewed the article, “Patient Perspectives on Choosing Buprenorphine Over Methadone in an Urban, Equal-Access System.”  View the February 2022 RSHR Reading group meeting summary that includes a brief article summary and key themes that arose in discussion with the participants.

In this session, Larissa Mooney, MD, one of two PIs for the Greater Southern California Node of the NIDA Clinical Trials Network, discussed recent trends in co-occurring methamphetamine use and opioid use disorder (OUD), including overdose fatalities. Participants also learned about the treatment approaches to address this rising comorbidity. This webinar was sponsored by the Northwest and Pacific Southwest ATTCs and the Western States Node of the NIDA Clinical Trials Network. Download slides

Happy December everyone! The holidays are here, and we wanted to share some words of encouragement to all of those who are striving for sober celebrations. #NHLATTC #NHLPTTC #Holidays #sobercelebrations #recoveryjourney #peersupport Disponible en Español ¡Feliz mes de diciembre a todos! Las fiestas están por comenzar, y queremos compartir algunas palabras de aliento a todos aquellos en recuperación que se esfuerzan por tener celebraciones libre de alcohol y drogas. #NHLATTC #NHLPTTC #Fiestas #celebracionessobrias #procesoderecuperación #apoyodecompañeros Disponible en Portugués Feliz dezembro à todos! As festas de final de ano estão chegando e gostaríamos de deixar algumas palavras de incentivo à todos aqueles em recuperação que estão se esforçando para ter celebrações sem álcool e drogas. #NHLATTC #NHLPTTC #Festas #sobercelebrations #recoveryjourney #peersupport

The September 2019 Dialogue features: Addiction: National Recovery Month | Mental Health: Learning Collaboratives | Prevention: Prescription Opioid and Heroin Awareness | ORN: LGBT+ Long-term Recovery | Region 3 Spotlight: Recovery Stories of Shirley J. Davis and Kathy Dorman. Additional sections include upcoming training and webinar events, behavioral health observances, new resources, and Region 3 news. The Dialogue is designed to inform behavioral and mental health professionals of news and upcoming events in the Central East states. This electronic newsletter is disseminated on the first Tuesday of each month. You are encouraged to provide us with any feedback or submit articles and topics for discussion in future issues of the newsletter. If you would like to be added to our mailing list to receive the Dialogue and news and training announcements, sign up here.           Recovery Stories: In this month's newsletter, two special and brave guest contributors shared their recovery stories for Recovery Month.   Shirley J. Davis For many years, I ran from the realities of my past life and tried extremely hard to hide from the knowledge that I continually lost time and felt like “someone else,” until the winter of my thirtieth year. I went to bed one night and as soon as I turned off the light to go to sleep, I relived a horrible memory of rape. I immediately turned the lights back on and lay shivering in my bed waiting for daylight. It was then that I knew I had to get help. Continue reading Shirley's story.     Kathy Dorman I’m so grateful to be a recovering addict, to still be alive to give others hope, because I remember the life of hopelessness. My passion is to reach children and young adults who may feel hopeless or peer pressured into trying drugs. As a child, I was surrounded by family and friends who were caught in the disease of addiction. I tell people, yes, I may have had a choice, but literally I had no chance, at least that’s how I felt. Continue reading Kathy's story.

Fueled by the opioid epidemic, hepatitis C infections have increased dramatically in rural communities in the Great Lakes Region. Since 2017, a consortium of academic, public health and community-based partners have undertaken abroad research program in six rural Wisconsin counties. The research team has surveyed more than 800 people who inject drugs and interviewed diverse stakeholders working on the public opioid response to inform best practices for reducing the spread of HIV, hepatitis and preventing overdose. In this 60-minute webinar, Principal Investigator Dr. Ryan Westergaard will review lessons learned through this research and describe how the communities plan to move forward with implementation of a client-centered prevention service coordination intervention starting in late 2019. PowerPoint Presentation Transcript  

Learn how addiction and infectious disease interact: Dr. Ryan Westergaard presents clinical issues related to the management of patients with infectious diseases and addiction, including important drug interactions, adherence support, and care coordination strategies.  Read the transcript: 

This one-hour, self-paced course on the HealtheKnowledge website is designed to equip peers and other outreach workers with information, resources, and practical tips to help them better understand opioids and their impact on individuals.  The course features four modules: Role of Peers in Recovery Opioids and the Brain Treatment Options Supporting Those Using Opioids Learn about effective treatment options and strategies for using person-centered care to engage people with opioid use disorder in their path to recovery. 1 NAADAC/NBCC CEU available!

Provides an overview of state resources and initiatives to address the opioid epidemic in Minnesota. Information effective May 2019.

Provides an overview of resources and initiatives to address opioid misuse in Illinois. Information effective May 2019.

Provides an overview of resources and initiatives to address opioid misuse in Indiana.  Information effective May 2019.

Provides an overview of resources and initiatives to address opioid misuse in Michigan. Information effective May 2019. 

Overview: Methamphetamine is the number 1 drug threat ranked by the Dallas, El Paso, and Houston DEA Field Divisions. Cocaine is ranked the number 2 and number 3 threat by the DEA Field Divisions. Pharmaceuticals, benzodiazepines, hydrocodone, and muscle relaxants remain problematic. Compared to other NDEWS sites, the number of fentanyl items seized and identified is increasing, but the number of cases involving heroin and fentanyl in combination is low, while the number of cases involving fentanyl and other opiates is high. The recent increase in the number of tramadol cases involved with other opiates is also a concern. Heroin in Texas is either black tar heroin or powdered brown heroin (diluted with diphenhydramine or other filler), with some white Mexican/South American heroin seen. Of the top 25 items seized and identified in Texas laboratories reporting to the National Forensic Laboratory Information System (NFLIS), heroin ranks #4, at 5.2% of all items identified, and fentanyl ranks #21 (0.21% of all items identified). Cannabis indicators remain steady, with problems most often seen in the trafficking of decriminalized cannabis products from Colorado through Texas. Synthetic cannabinoid and cathinone poison calls have decreased but recent research by the author looking at treatment admissions and poison center call data has found statistically significant trends over time. The user population has changed from younger males hoping to use a cannabinoid that would not show positive in drug tests to an older population who are more likely to be experiencing homelessness and co-morbid psychological problems.

This webinar, held in November 2018, was sponsored by the Northwest ATTC and the Western States Node of the NIDA Clinical Trials Network. It reviews the biological basis of medications for opioid use disorder, reviews recent data on the effects of buprenorphine on patient outcomes, and introduces tools for integrating buprenorphine treatment into your current treatment setting. Presenter: P. Todd Korthuis, MD, MPH, Oregon Health & Science University, NIDA Clinical Trials Network Western States Node Download slides | Watch recording

J. Paul Seale, MD, Certified by the American Boards of Family Medicine and Addiction Medicine, discusses America’s ongoing opioid epidemic. By the end of this one hour program, participants should be able to: 1) identify several key developments in the origin of the opioid epidemic, 2) describe strategic initiatives that are in progress to address the epidemic, and 3) identify specific steps forward that could help address the epidemic.